SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is trending amid mixed sentiment, with community members debating whether recent price movements are sustainable or just a "dead cat bounce." Some traders are pointing to potential catalysts like staking rewards and broader crypto market trends, while others warn of a possible downturn and label the token a "sucker coin."

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending amid broader crypto market volatility, with community members debating potential price movements and Elon Musk's influence. Discussions range from holding strategies to skepticism about future gains, with some anticipating a potential pump and others bracing for further consolidation. The potential launch of an ETF may be driving some optimism.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending amid community discussion around its potential for growth and recent options activity. Some investors express frustration with the stock's recent performance despite analyst ratings, while others remain confident in the long-term vision and potential acquisitions led by Brad Jacobs. The community is actively discussing entry and exit points, with many expressing a bullish outlook.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors digest the company's recent earnings, with some highlighting a narrower-than-expected loss and revenue growth. The community is actively discussing the potential impact of Rivian's AI and robotics initiatives, as well as upcoming catalysts like Autonomy Day. Despite some skepticism, optimism is fueled by Amazon's significant stake and hopes for the R2 model's success.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending due to community discussion around high borrow fees and potential short squeeze, as some retail investors report difficulty lending shares. Traders are debating the impact of dark pool trading and synthetic short positions, suggesting shorts are trapped and retail accumulation is key. Overall, the community is closely watching borrow rates, float size, and potential for a squeeze amid unusual trading activity.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer's pursuit of Metsera has intensified, with the company filing a second lawsuit against Novo Nordisk amidst a heated bidding war, driving significant community discussion around the potential acquisition's impact on the competitive landscape of obesity therapeutics. Community members are debating whether Pfizer is overpaying and if the acquisition aligns with their long-term strategy, especially given the existing competition in the weight loss market; at the same time, there's also discussion of Michael Burry's new position in PFE.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO Group is trending due to a mix of factors including record high ICE detainee populations and analyst upgrades, with community members weighing in on potential future price movements and government contracts. Discussions also involve share buybacks and comparing GEO's performance to similar companies, along with the impact of potential policy changes. Option traders are active, speculating on future gains with calls expiring in 2027.

CommScope Holding Co., Inc. engages in the provision of infrastructure solutions for communication, data center, and entertainment networks. It operates through the following segments: Connectivity and Cable Solutions (CCS), Networking, Intelligent Cellular and Security Solutions (NICS), Access Network Solutions (ANS), and Corporate and Other. The CCS segment focuses on fiber optic, copper connectivity, and cable solutions for use in telecommunications, cable television, residential broadband networks, data centers, and business enterprises. The NICS segment provides wireless networks for enterprises and service providers. The ANS segment refers to the cable modem termination systems, video infrastructure, distribution and transmission equipment, and cloud solutions that enable facility-based service providers to construct a residential and metro distribution network. The company was founded by Frank M. Drendel in 1976 and is headquartered in Claremont, NC.

CommScope Holding Company Inc

COMM is trending following a strong earnings report and news of its Connectivity and Cable Solutions business sale to Amphenol for $10.5 billion, leading to discussions about debt reduction and potential shareholder dividends. Community members are debating the future valuation of the company post-sale, with bulls highlighting the remaining high-growth segments and bears pointing to the loss of a significant revenue stream. Some traders are closely watching for potential manipulation and directional plays based on technical indicators and options activity.

Diageo Plc engages in the production and distribution of alcoholic beverages. The firm brands include Johnnie Walker, Crown Royal, J&B and Buchanan’s whiskies, Smirnoff, Ciroc and Ketel One vodkas, Captain Morgan, Baileys, Don Julio, Casamigos, Tanqueray, and Guinness. It operates through the following geographical segments: North America, Europe, Asia Pacific, Latin America and Caribbean, Africa, and Corporate and Other. The company was founded on October 21, 1886 and is headquartered in London, the United Kingdom.

Diageo plc - ADR

Diageo plc

Diageo's (DEO) stock is trending amidst discussions around recent performance and future outlook, with some investors seeing a buying opportunity due to a perceived discount relative to intrinsic value and peers. Community members are weighing factors like tariff impacts, sales trends in emerging markets, and shifting consumer preferences among younger generations. Options activity and analyst ratings are also fueling the conversation, with some suggesting a potential for both upside and downside.

Akamai Technologies, Inc. engages in the provision of cloud services for delivering, optimizing, and securing content and business applications over the Internet. Its products include security, web performance, media delivery, and network operator. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamai is trending following a Q3 earnings beat, driven by strong security and cloud computing growth, fueling discussions about the company's ongoing transformation. Community members are reacting positively to the results and raised guidance, with some analysts increasing price targets. The company's expansion in edge computing and AI is also a key talking point.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FY2027 Earnings Estimate for MIRM Issued By Leerink Partnrs

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) - Investment analysts at Leerink Partnrs raised their FY2027 earnings estimates for Mirum Pharmaceuticals in a research report issued to...

Research Analysts Offer Predictions for MIRM FY2028 Earnings

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) - Analysts at HC Wainwright boosted their FY2028 earnings per share (EPS) estimates for shares of Mirum Pharmaceuticals in a research note...

Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI and Volixibat Clinical Programs at AASLDs The Liver Meeting

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that multiple presentations featuring data from its LIVMARLI (maralixibat) and volixibat clinical programs...

Mirum Pharmaceuticals (NASDAQ:MIRM) Posts Earnings Results, Beats Expectations By $0.15 EPS

Mirum Pharmaceuticals (NASDAQ:MIRM - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate...

Citizens Jmp Forecasts Strong Price Appreciation for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock

Citizens Jmp upped their target price on Mirum Pharmaceuticals from $81.00 to $95.00 and gave the company a "market outperform" rating in a research report on Wednesday...

MIRM's Q3 Earnings & Revenues Beat Estimates, 2025 View Tightened

Mirum posts third-quarter profit and stronger revenues on surging Livmarli demand, while tightening its 2025 sales outlook.

Mirum Pharmaceuticals, Inc. (MIRM) Surpasses Q3 Earnings and Revenue Estimates

Mirum Pharmaceuticals (MIRM) delivered earnings and revenue surprises of +150.00% and +0.85%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the third quarter 2025 and provided a business update. Mirum is well positioned heading into 2026 with strong...

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and...

Techne (TECH) Reports Next Week: What to Know Ahead of the Release

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Mirum Pharmaceuticals Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$68.11
Prev Close	$67.72
Open	$67.08
Dividend Yield	0.00%
50-Day Moving Average	$72.95
Beta	0.76
Avg. Volume	578,376.83
PE Ratio	-79.03

52-Week High	$78.54
52-Week Low	$36.88
Market Capitalization	$3.5B
EPS (Annual)	-$1.85
Price to Book	11.97
Revenue Per Employee	$1.05M
Enterprise Value/EBITDA	N/A

MIRM
Mirum Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MIRM News

MIRMMirum Pharmaceuticals Inc